Breaking

Archive

Jul 2 results
20:05
20:05

New Drug Prevents HIV Among Ugandan And South African Women Gilead Sciences Inc 3 Top story

A twice-yearly injection has the potential to transform the way to deliver HIV prevention to people who need and want it most. It is the first big trial to reduce HIV infections to zero.
23:34
23:34

Early Trial Results for Remdesivir Show Promise in COVID-19 Treatment Gilead Sciences Inc 1

The National Institute of Allergy and Infectious Diseases trial reportedly found that Remdesivir Accelerates Recovery from Advanced COVID-19 and that patients had a 31 per cent faster time to recovery than those who received placebo.
Jul 2 results